{"id":3567,"date":"2009-04-03T07:45:11","date_gmt":"2009-04-03T04:45:11","guid":{"rendered":"http:\/\/www.ced.org.tr\/?p=3567"},"modified":"2009-04-03T07:45:11","modified_gmt":"2009-04-03T04:45:11","slug":"2008-sutda-degisiklik-tebligi","status":"publish","type":"post","link":"http:\/\/www.ced.org.tr\/?p=3567","title":{"rendered":"2008 SUT&#8217;da De\u011fi\u015fiklik Tebli\u011fi"},"content":{"rendered":"<p>SGK taraf\u0131ndan 3 Nisan 2009 tarih ve 27189 say\u0131l\u0131 Resmi Gazete&#8217;de yay\u0131mlanan <strong>&#8220;2008 Y\u0131l\u0131 Sosyal G\u00fcvenlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011finde De\u011fi\u015fiklik Yap\u0131lmas\u0131na Dair Tebli\u011f&#8221; <\/strong>a\u015fa\u011f\u0131da yer almaktad\u0131r. <\/p>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"0\" width=\"486\" class=\"MsoNormalTable\" align=\"center\" style=\"width: 486px; border-collapse: collapse; height: 55px\">\n<tbody>\n<tr style=\"height: 15.85pt\">\n<td width=\"195\" style=\"border-bottom: #660066 1pt solid; border-left: #ece9d8; padding-bottom: 0cm; background-color: transparent; padding-left: 5.4pt; width: 146.55pt; padding-right: 5.4pt; height: 15.85pt; border-top: #ece9d8; border-right: #ece9d8; padding-top: 0cm\">\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"MsoNormal\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">3 Nisan 2009 CUMA<\/span><\/span><\/p>\n<\/td>\n<td width=\"195\" style=\"border-bottom: #660066 1pt solid; border-left: #ece9d8; padding-bottom: 0cm; background-color: transparent; padding-left: 5.4pt; width: 146.55pt; padding-right: 5.4pt; height: 15.85pt; border-top: #ece9d8; border-right: #ece9d8; padding-top: 0cm\">\n<p style=\"text-align: center; line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"MsoNormal\" align=\"center\"><strong><span style=\"color: purple; font-size: 11pt\"><span style=\"font-family: Times New Roman\">Resm\u00ee Gazete<\/span><\/span><\/strong><\/p>\n<\/td>\n<td width=\"195\" style=\"border-bottom: #660066 1pt solid; border-left: #ece9d8; padding-bottom: 0cm; background-color: transparent; padding-left: 5.4pt; width: 146.35pt; padding-right: 5.4pt; height: 15.85pt; border-top: #ece9d8; border-right: #ece9d8; padding-top: 0cm\">\n<p style=\"text-align: right\" align=\"right\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">Say\u0131 : 27189<\/span><\/span><\/p>\n<\/td>\n<\/tr>\n<tr style=\"height: 24pt\">\n<td colspan=\"3\" width=\"586\" style=\"padding-bottom: 0cm; background-color: transparent; padding-left: 5.4pt; width: 439.45pt; padding-right: 5.4pt; height: 24pt; padding-top: 0cm; border: #ece9d8\">\n<p style=\"text-align: center\" align=\"center\"><strong><span style=\"color: navy; font-size: 11pt\"><span style=\"font-family: Times New Roman\">TEBL\u0130\u011e<\/span><\/span><\/strong><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"line-height: 12pt; text-indent: 1cm; margin: 0cm 0cm 0pt\" class=\"1-baslk\"><span style=\"text-decoration: underline\"><span style=\"font-size: small\"><span style=\"font-family: Times New Roman\"><font size=\"2\">Sosyal G\u00fcvenlik Kurumundan:<\/font><\/span><\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"2-ortabaslk\"><span style=\"font-size: 11pt\"><strong><span style=\"font-family: Times New Roman\">2008 YILI SOSYAL G\u00dcVENL\u0130K KURUMU SA\u011eLIK UYGULAMA<\/span><\/strong><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"2-ortabaslk\"><span style=\"font-size: 11pt\"><strong><span style=\"font-family: Times New Roman\">TEBL\u0130\u011e\u0130NDE DE\u011e\u0130\u015e\u0130KL\u0130K YAPILMASINA DA\u0130R TEBL\u0130\u011e<\/span><\/strong><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 1 \u2013<\/strong> 29\/9\/2008 tarihli ve 27012 say\u0131l\u0131 birinci m\u00fckerrer Resm\u00ee Gazete\u2019de yay\u0131mlanan \u201c2008 Y\u0131l\u0131 Sosyal G\u00fcvenlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011fi\u201dnin (12) numaral\u0131 maddesinde a\u015fa\u011f\u0131da belirtilen d\u00fczenlemeler yap\u0131lm\u0131\u015ft\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 a) SUT\u2019un (12.7.9) numaral\u0131 maddesinin (c) bendinin \u00fc\u00e7\u00fcnc\u00fc f\u0131kras\u0131 a\u015fa\u011f\u0131daki \u015fekilde d\u00fczenlenmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201c\u0130lgili ko\u015fullar\u0131n s\u00f6z konusu oldu\u011fu hemodiyaliz tedavisi alt\u0131ndaki hastalarda nefroloji veya diyaliz sertifikal\u0131 i\u00e7 hastal\u0131klar\u0131\/\u00e7ocuk sa\u011fl\u0131\u011f\u0131 ve hastal\u0131klar\u0131 uzman hekimlerinden birinin d\u00fczenledi\u011fi sa\u011fl\u0131k raporuna istinaden 3 ayl\u0131k dozda bu hekimlerce veya diyaliz sertifikal\u0131 t\u00fcm hekimler taraf\u0131ndan re\u00e7ete edilebilir\u201d<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 b) SUT\u2019un (12.7.13) numaral\u0131 maddesinin (A) bendinin 4 \u00fcnc\u00fc maddesinin \u00fc\u00e7\u00fcnc\u00fc f\u0131kras\u0131nda yer alan \u201cStabil HIV ve naiv HCV ko-enfeksiyonlar\u0131nda\u201d ifadesi \u00e7\u0131kar\u0131larak yerine, \u201cKronik Hepatit C tedavisinde\u201d\u00a0 ifadesi eklenmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 c) SUT\u2019un (12.7.14) numaral\u0131 maddesinin (c) bendinin (3) numaral\u0131 maddesinin (d) alt bendinin son f\u0131kras\u0131na \u201cLapatinib + kapesitabin kullan\u0131l\u0131yor iken progresyon geli\u015fen hastalarda tedavinin sonraki basamaklar\u0131nda Lapatinib \u00f6denmez\u201d ifadesinden sonra gelmek \u00fczere \u201cT\u0131bbi onkoloji uzman hekiminin bulundu\u011fu t\u00fcm hastanelerde bu hekimin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporu ile bu hekimlerce re\u00e7ete edilir. T\u0131bbi onkoloji uzman hekiminin bulunmad\u0131\u011f\u0131 3.basamak sa\u011fl\u0131k kurumlar\u0131nda ise genel cerrahi uzman hekiminin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporu ile ve yine 3. basamak sa\u011fl\u0131k tesislerinde genel cerrahi uzman hekimince re\u00e7ete edilir.\u201d ibaresi eklenmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong><span style=\"color: red\">d) SUT\u2019un (12.7.17) numaral\u0131 maddesinin (1) numaral\u0131 maddesinin (B) bendi ba\u015fl\u0131\u011f\u0131 a\u015fa\u011f\u0131daki \u015fekilde de\u011fi\u015ftirilmi\u015ftir.<\/span><\/strong><\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><strong><span style=\"color: red; font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201cB. Di\u011fer nedenlere ba\u011fl\u0131 osteopeni\/osteoporozda (T-skorunun < -1 olmas\u0131)\u201d<\/span><\/span><\/strong><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 e) SUT\u2019un (12.7.20) numaral\u0131 maddesinin birinci f\u0131kras\u0131nda \u201cPalivizumab etken maddesini ta\u015f\u0131yan preparat\u0131n\u201d ifadesinden sonra gelmek \u00fczere \u201c\u00e7ocuk kardiyoloji,\u201d ibaresi eklenmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong><span style=\"color: red\">f) SUT\u2019un (12.7.28) numaral\u0131 maddesinin (C) bendinde yer alan\u00a0 \u201cLDL veya trigliserid d\u00fczeyi 100 mg\/dl\u2019nin alt\u0131na d\u00fc\u015ft\u00fckten sonra re\u00e7ete edildi\u011finde bedeli \u00f6denmez\u201d ibaresi \u201cLDL d\u00fczeyi 100 mg\/dl\u2019nin alt\u0131na veya trigliserid d\u00fczeyi 200 mg\/dl\u2019nin alt\u0131na d\u00fc\u015ft\u00fckten sonra re\u00e7ete edildi\u011finde bedeli \u00f6denmez\u201d \u015feklinde de\u011fi\u015ftirilmi\u015ftir.<\/span><\/strong><\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 2 \u2013 <\/strong>SUT\u2019un (20.2.1) numaral\u0131 maddesinin (b) bendi a\u015fa\u011f\u0131daki \u015fekilde yeniden d\u00fczenlenmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-family: Times New Roman\"><strong><span style=\"font-size: 11pt\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201cb) \u00d6zel sa\u011fl\u0131k kurumlar\u0131nda; <\/span><\/strong><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 1. S\u00f6zle\u015fmeli \u00f6zel sa\u011fl\u0131k kurumlar\u0131nca temin edilen SUT eki Listelerde yer alan malzemeler, SUT eki listelerde belirlenen birim fiyatlar \u00fczerinden, <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 2. SUT ve eki listelerde yer almayan t\u0131bbi malzemelerden; <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 a) Kurum (devredilen T.C. Emekli Sand\u0131\u011f\u0131) ile protokoll\u00fc firmalar\u0131n protokol d\u00e2hili malzemeleri protokol fiyatlar\u0131 \u00fczerinden, <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 b) Protokoll\u00fc firmalar\u0131n protokol d\u00e2hilinde olmayan t\u0131bbi malzemeler ile Kurumla (devredilen T.C. Emekli Sand\u0131\u011f\u0131) protokol\u00fc olmayan firmalardan temin edilen malzemeler, Kurum (devredilen T.C. Emekli Sand\u0131\u011f\u0131) t\u0131bbi malzeme listelerinde tespit edilen ve Kurum ta\u015fra te\u015fkilat\u0131 inceleme birimlerince benzer nitelikte, ayn\u0131 i\u015flevsel \u00f6zellikte ve ayn\u0131 t\u0131bbi sonucu verdi\u011fi kabul edilen en ucuz malzeme bedeli \u00fczerinden, (devredilen T.C. Emekli Sand\u0131\u011f\u0131 ile protokol\u00fc iptal edilen t\u0131bbi malzemelerin protokol fiyatlar\u0131, \u00f6denecek bedel tespitinde dikkate al\u0131n\u0131r)<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 c) (a) ve (b) bentlerine g\u00f6re Kurum (devredilen T.C. Emekli Sand\u0131\u011f\u0131) t\u0131bbi malzeme listelerinde fiyat\u0131 tespit edilemeyen t\u0131bbi malzemeler, KDV d\u00e2hil al\u0131\u015f fiyat\u0131 \u00fczerinden, <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Kuruma fatura edilen tutar\u0131 a\u015fmamak \u015fart\u0131yla \u00f6denir. <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00d6zel sa\u011fl\u0131k kurumunca yatarak tedavilerde temini zorunlu t\u0131bbi malzemelerin re\u00e7ete kar\u015f\u0131l\u0131\u011f\u0131 hastaya ald\u0131r\u0131lmas\u0131 durumunda; fatura tutar\u0131 hastaya \u00f6denerek ilgili sa\u011fl\u0131k kurumunun alaca\u011f\u0131ndan mahsup edilir.\u201d <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 3 \u2013 <\/strong>SUT\u2019un (20.3.7) numaral\u0131 maddesinin d\u00f6rd\u00fcnc\u00fc f\u0131kras\u0131 a\u015fa\u011f\u0131daki \u015fekilde de\u011fi\u015ftirilmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201c(4) Odyoloji test sonu\u00e7lar\u0131n\u0131 g\u00f6sterir belgenin asl\u0131 rapora eklenecektir. Odyoloji testlerinin, Kurumla s\u00f6zle\u015fmeli sa\u011fl\u0131k kurumlar\u0131nda\/kurulu\u015flar\u0131nda veya raporu d\u00fczenleyen sa\u011fl\u0131k kurumunun hizmet al\u0131m s\u00f6zle\u015fmesi yapt\u0131\u011f\u0131 sa\u011fl\u0131k kurumlar\u0131nca\/kurulu\u015flar\u0131nca yap\u0131lmas\u0131 ve odyometrist veya i\u015fitme testi yapmaya yetkili sertifikal\u0131 personel taraf\u0131ndan onaylanm\u0131\u015f olmas\u0131 halinde kabul edilecektir.\u201d<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 4 \u2013 <\/strong>SUT\u2019un (20.3.13.1) numaral\u0131 maddesinde a\u015fa\u011f\u0131daki d\u00fczenlemeler yap\u0131lm\u0131\u015ft\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><strong><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201c20.3.13.1 Koklear implantlar (K\u0130):<\/span><\/span><\/strong><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Koklear implant, bilateral ileri-\u00e7ok ileri derecede sens\u00f6rin\u00f6ral i\u015fitme kayb\u0131 olan ve i\u015fitme cihaz\u0131ndan yarar g\u00f6rmeyen ki\u015filerde a\u015fa\u011f\u0131daki kriterlere haiz olmas\u0131 halinde uygulan\u0131r;<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u2022 Pre-lingual i\u015fitme kayb\u0131 olan \u00e7ocuklarda (i\u015fitme cihaz\u0131 hi\u00e7 kullanmam\u0131\u015f olanlar da dahil) 6 ya\u015f\u0131n\u0131 tamamlay\u0131ncaya kadar K\u0130 uygulan\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 7 ya\u015f ve \u00fczeri pre-lingual i\u015fitme kayb\u0131 olan \u00e7ocuklarda kronolojik ya\u015fla konu\u015fma ya\u015f\u0131 aras\u0131ndaki fark 4 y\u0131ldan az ise K\u0130 uygulamas\u0131 yap\u0131l\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 Post-lingual i\u015fitme kayb\u0131 olanlarda K\u0130 uygulan\u0131r, ancak hi\u00e7 i\u015fitme cihaz\u0131 kullanmam\u0131\u015f post-lingual i\u015fitme kayb\u0131 olanlarda 10 y\u0131l ge\u00e7mesi halinde K\u0130 uygulanmaz. <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 K\u0130 kurul raporu ayn\u0131 resmi sa\u011fl\u0131k kurumunda \u00e7al\u0131\u015fan \u00fc\u00e7 kulak burun bo\u011faz uzman hekimi ve iki uzman odyologdan (iki uzman odyolog bulunmayan resmi sa\u011fl\u0131k kurumlar\u0131nda ise 1.1.2010 tarihine kadar bir odyolog veya uzman odyolog) olu\u015fan bir ekip taraf\u0131ndan d\u00fczenlenir. <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 Elektrod yerle\u015fimini sa\u011flayacak kadar i\u00e7 kulak geli\u015fiminin olmas\u0131 ve koklear sinirin varl\u0131\u011f\u0131 y\u00fcksek \u00e7\u00f6z\u00fcn\u00fcrl\u00fckte CT ve\/veya MRI ile g\u00f6sterilmelidir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 E\u011fitimsel, psikolojik de\u011ferlendirmeler ve uygunlu\u011fu ekipte yer alan e\u011fitim odyolo\u011fu (bulunmayan kurumlarda i\u015fitme engelliler alan\u0131nda deneyimli \u00f6zel e\u011fitimci veya psikolog) ve psikolog taraf\u0131ndan yap\u0131lmal\u0131 ve K\u0130 kurul raporunda belirtilmelidir. <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 Menenjit sonras\u0131 olu\u015fan i\u015fitme kayb\u0131 ve koklear ossifikasyon varl\u0131\u011f\u0131nda \u00f6zel \u015fartlar aranmaks\u0131z\u0131n acil operasyon K\u0130 kurul raporu ile belgelendirilmesi halinde yap\u0131l\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 \u0130\u015fitsel N\u00f6ropati\u2019de ayr\u0131nt\u0131l\u0131 de\u011ferlendirmeler sonunda K\u0130 uygulamas\u0131n\u0131n yararl\u0131 olaca\u011f\u0131 K\u0130 kurul raporu ile belgelendirilmesi halinde yap\u0131l\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u2022 K\u0130 uygulamas\u0131 sonras\u0131ndaki e\u011fitimin takibi; cerrahi tedavi yap\u0131lan sa\u011fl\u0131k kurumunca; e\u011fitim odyolo\u011fu (bulunmayan kurumlarda i\u015fitme engelliler alan\u0131nda deneyimli \u00f6zel e\u011fitimci veya psikolog) ve yer belirtilerek en az 5 y\u0131ll\u0131k s\u00fcreyi i\u00e7eren bir taahh\u00fctname ile belgelenmelidir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-family: Times New Roman\"><strong><span style=\"font-size: 11pt\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Odyolojik De\u011ferlendirme:<\/span><\/strong><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Odyometrik de\u011ferlendirme,<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Saf ses hava yolu ve kemik yolu i\u015fitme e\u015fikleri; 1000, 2000, 3000 ve 4000 Hz\u2019lerdeki ortalama e\u015fiklerin 90 dB\u2019den daha k\u00f6t\u00fc olmas\u0131 ve i\u015fitme cihaz\u0131 ile konu\u015fmay\u0131 ay\u0131rdetme skorunun %30\u2019un alt\u0131nda olmal\u0131d\u0131r.\u201d<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 5 \u2013 <\/strong>SUT\u2019un \u201c\u0130kinci ve \u00fc\u00e7\u00fcnc\u00fc basamak sa\u011fl\u0131k kurumlar\u0131na \u00f6deme\u201d ba\u015fl\u0131kl\u0131 (24.1.1.2) numaral\u0131 maddesinin dokuzuncu f\u0131kras\u0131 a\u015fa\u011f\u0131daki \u015fekilde de\u011fi\u015ftirilmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201c(9) Hastan\u0131n 10 g\u00fcn i\u00e7inde ayaktan ilk ba\u015fvurusundan sonraki ayn\u0131 dala ayaktan ba\u015fvurular\u0131n\u0131n ayn\u0131 sa\u011fl\u0131k kurumuna olmas\u0131 halinde sadece SUT eki EK\u201310\/C Listesinde yer alan i\u015flem bedelleri ile genetik tetkiklerin bedelleri faturaland\u0131r\u0131labilir.\u201d<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 6 \u2013 <\/strong>SUT\u2019un \u201cY\u00fcr\u00fcrl\u00fck\u201d ba\u015fl\u0131kl\u0131 (29) numaral\u0131 maddesinin (b) bendi a\u015fa\u011f\u0131daki \u015fekilde de\u011fi\u015ftirilmi\u015ftir.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201cb) SUT eki EK-8\/A Listesi Kurumca duyurulacak tarihte,\u201d<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 7 \u2013 <\/strong>SUT eki \u201cEK-2\/A\u201d 197\u2019nci maddede \u201cklinik immunoloji\u2026\u2026\u201d ile ba\u015flayan parantez i\u00e7i ifade, a\u015fa\u011f\u0131da belirtildi\u011fi \u015fekilde yeniden d\u00fczenlenmi\u015ftir. <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201c(klinik immunoloji, allerji, g\u00f6\u011f\u00fcs hastal\u0131klar\u0131 uzmanl\u0131k dallar\u0131ndan en az ikisinin bulundu\u011fu 3 uzman hekimin yer ald\u0131\u011f\u0131 sa\u011fl\u0131k kurulu raporuna istinaden yine bu uzmanlar taraf\u0131ndan re\u00e7ete edilir)\u201d<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 8 \u2013 <\/strong>SUT eki \u201cFiyatland\u0131r\u0131lm\u0131\u015f T\u0131bbi Sarf Malzemeleri Listesi\u201d nde (EK-5\/A) a\u015fa\u011f\u0131daki d\u00fczenlemeler yap\u0131lm\u0131\u015ft\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 300.996 kod numaral\u0131 \u201cmikro inf\u00fczyon pompa seti ve resorvo\u0131r\u201d\u00a0 ve 390.020 kod numaral\u0131 \u201cprogesteronlu spiral (rahim i\u00e7i ara\u00e7)\u201d listeden \u00e7\u0131kar\u0131lm\u0131\u015ft\u0131r.<\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-family: Times New Roman\"><strong><span style=\"font-size: 11pt\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MADDE 9 \u2013 <\/span><\/strong><span style=\"font-size: 11pt\">SUT eki \u201cSa\u011fl\u0131k Kurumlar\u0131 Fiyat Listesi\u201d nde (EK-8) 4992 s\u0131ra no\u2019da yer alan \u201cMESLEK HASTALIKLARI LABORATUAR TETK\u0130KLER\u0130\u201d b\u00f6l\u00fcm\u00fcn\u00fcn \u201cA\u00c7IKLAMA\u201d k\u0131sm\u0131nda yer alan \u201cBu tetkikler, meslek hastal\u0131klar\u0131n\u0131n tespit edilmesi amac\u0131yla sevk edilen hastalara yap\u0131lmas\u0131 halinde \u00f6denir.\u201d ibaresi \u201cBu tetkiklerin bedelleri, meslek hastal\u0131klar\u0131 hastanelerince yap\u0131lmas\u0131 halinde \u00f6denir.\u201d \u015feklinde de\u011fi\u015ftirilmi\u015ftir. <\/span><\/span><\/p>\n<p style=\"line-height: 12pt; margin: 0cm 0cm 0pt\" class=\"3-normalyaz\"><span style=\"font-family: Times New Roman\"><strong><span style=\"font-size: 11pt\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MADDE 10 \u2013 <\/span><\/strong><span style=\"font-size: 11pt\">Bu Tebli\u011fin (1) numaral\u0131 maddesinin (b) bendi 5\/12\/2008, (d) bendi 31\/12\/2008, (5) ve (6) numaral\u0131 maddeleri 1\/4\/2009 tarihinde, di\u011fer h\u00fck\u00fcmleri yay\u0131m\u0131 tarihinde y\u00fcr\u00fcrl\u00fc\u011fe girer. <\/span><\/span><\/p>\n<p style=\"text-align: justify; margin: 0cm 0cm 0pt\" class=\"MsoNormal\"><span style=\"font-size: 11pt\"><span style=\"font-family: Times New Roman\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <strong>MADDE 11 \u2013 <\/strong>Bu Tebli\u011f h\u00fck\u00fcmlerini Sosyal G\u00fcvenlik Kurumu Ba\u015fkan\u0131 y\u00fcr\u00fct\u00fcr.<\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SGK taraf\u0131ndan 3 Nisan 2009 tarih ve 27189 say\u0131l\u0131 Resmi Gazete&#8217;de yay\u0131mlanan &#8220;2008 Y\u0131l\u0131 Sosyal G\u00fcvenlik Kurumu Sa\u011fl\u0131k Uygulama Tebli\u011finde&#46;&#46;&#46;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3567","post","type-post","status-publish","format-standard","hentry","category-ced"],"aioseo_notices":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"_links":{"self":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3567","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3567"}],"version-history":[{"count":0,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=\/wp\/v2\/posts\/3567\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3567"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3567"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.ced.org.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3567"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}